O	O	0	7	Nuclear	Nuclear	B-NP	JJ	O	2	NMOD	O
O	O	8	14	levels	level	I-NP	NNS	O	7	SUB	O
O	O	15	17	of	of	B-PP	IN	O	2	NMOD	O
T2	B-Entity	18	20	NF	NF	B-NP	NN	B-protein	6	NMOD	B-protein
T2	I-Entity	20	21	-	-	B-NP	HYPH	I-protein	6	NMOD	I-protein
T2	I-Entity	21	27	kappaB	kappaB	I-NP	NN	I-protein	3	PMOD	I-protein
O	O	28	37	correlate	correlate	B-VP	VBP	O	0	ROOT	O
O	O	38	42	with	with	B-PP	IN	O	7	VMOD	O
O	O	43	52	syncytium	syncytium	B-NP	NN	O	8	PMOD	O
O	O	52	53	-	-	O	HYPH	O	9	P	O
O	O	53	60	forming	form	B-VP	VBG	O	9	NMOD	O
O	O	61	69	capacity	capacity	B-NP	NN	O	11	OBJ	O
O	O	70	72	of	of	B-PP	IN	O	12	NMOD	O
O	O	73	77	8e51	8e51	B-NP	NN	B-cell_line	15	NMOD	B-cell_line
O	O	78	83	cells	cell	I-NP	NNS	I-cell_line	13	PMOD	I-cell_line
O	O	83	84	,	,	O	,	O	15	P	O
O	O	85	95	expressing	express	B-VP	VBG	O	15	NMOD	O
O	O	96	97	a	a	B-NP	DT	O	21	NMOD	O
O	O	98	107	defective	defective	I-NP	JJ	O	21	NMOD	O
O	O	108	111	HIV	HIV	I-NP	NN	O	21	NMOD	O
O	O	112	117	virus	virus	I-NP	NN	O	17	OBJ	O
O	O	117	118	.	.	O	.	O	7	P	O

O	O	120	123	The	The	B-NP	DT	O	6	NMOD	O
T3	B-Entity	124	130	double	double	I-NP	JJ	O	6	NMOD	O
T3	I-Entity	131	133	NF	NF	I-NP	NN	O	6	NMOD	O
T3	I-Entity	133	134	-	-	I-NP	HYPH	O	6	NMOD	O
T3	I-Entity	134	140	kappaB	kappaB	I-NP	NN	B-DNA	6	NMOD	B-DNA
T3	I-Entity	141	145	site	site	I-NP	NN	I-DNA	23	SUB	I-DNA
O	O	146	156	identified	identify	B-VP	VBN	O	6	NMOD	O
O	O	157	159	in	in	B-PP	IN	O	7	VMOD	O
O	O	160	163	the	the	B-NP	DT	O	10	NMOD	O
T5	B-Entity	164	167	LTR	LTR	I-NP	NN	B-DNA	8	PMOD	B-DNA
O	O	168	170	of	of	B-PP	IN	O	10	NMOD	O
O	O	171	174	the	the	B-NP	DT	O	15	NMOD	O
O	O	175	180	human	human	I-NP	JJ	O	15	NMOD	O
O	O	181	197	immunodeficiency	immunodeficiency	I-NP	NN	O	15	NMOD	O
O	O	198	203	virus	virus	I-NP	NN	O	11	PMOD	O
O	O	203	204	-	-	B-NP	HYPH	O	15	NMOD	O
O	O	204	205	1	1	I-NP	CD	O	16	PMOD	O
O	O	206	207	(	(	O	(	O	22	DEP	O
O	O	207	210	HIV	HIV	B-NP	NN	O	21	NMOD	O
O	O	210	211	-	-	B-NP	HYPH	O	21	P	O
O	O	211	212	1	1	I-NP	CD	O	22	DEP	O
O	O	212	213	)	)	O	)	O	17	NMOD	O
O	O	214	217	has	have	B-VP	VBZ	O	0	ROOT	O
O	O	218	222	been	be	I-VP	VBN	O	23	VC	O
O	O	223	235	demonstrated	demonstrate	I-VP	VBN	O	24	VC	O
O	O	236	238	to	to	I-VP	TO	O	27	VMOD	O
O	O	239	241	be	be	I-VP	VB	O	25	VMOD	O
O	O	242	251	necessary	necessary	B-ADJP	JJ	O	27	PRD	O
O	O	252	255	for	for	B-PP	IN	O	28	AMOD	O
O	O	256	265	efficient	efficient	B-NP	JJ	O	32	NMOD	O
O	O	266	271	viral	viral	I-NP	JJ	O	32	NMOD	O
O	O	272	285	transcription	transcription	I-NP	NN	O	29	PMOD	O
O	O	285	286	.	.	O	.	O	23	P	O

O	O	287	289	In	In	B-PP	IN	O	5	VMOD	O
O	O	290	294	this	this	B-NP	DT	O	3	NMOD	O
O	O	295	301	report	report	I-NP	NN	O	1	PMOD	O
O	O	302	304	we	we	B-NP	PRP	O	5	SUB	O
O	O	305	312	present	present	B-VP	VBP	O	0	ROOT	O
O	O	313	316	the	the	B-NP	DT	O	7	NMOD	O
O	O	317	333	characterisation	characterisation	I-NP	NN	O	5	OBJ	O
O	O	334	336	of	of	B-PP	IN	O	7	NMOD	O
O	O	337	339	NF	NF	B-NP	NN	B-protein	12	NMOD	B-protein
O	O	339	340	-	-	B-NP	HYPH	I-protein	12	NMOD	I-protein
O	O	340	346	kappaB	kappaB	I-NP	NN	I-protein	12	NMOD	I-protein
O	O	347	355	subunits	subunit	I-NP	NNS	I-protein	8	PMOD	I-protein
O	O	356	363	engaged	engage	B-VP	VBN	O	12	NMOD	O
O	O	364	366	in	in	B-PP	IN	O	13	VMOD	O
T6	B-Entity	367	376	complexes	complex	B-NP	NNS	O	14	PMOD	O
O	O	377	384	binding	bind	B-VP	VBG	O	15	NMOD	O
O	O	385	387	to	to	B-PP	TO	O	16	VMOD	O
O	O	388	391	the	the	B-NP	DT	O	25	NMOD	O
T7	B-Entity	392	395	HIV	HIV	I-NP	NN	O	25	NMOD	O
T7	I-Entity	395	396	-	-	O	HYPH	O	25	NMOD	O
T7	I-Entity	396	397	1	1	B-NP	CD	O	25	NMOD	O
T7	I-Entity	398	400	NF	NF	I-NP	NN	O	25	NMOD	O
T7	I-Entity	400	401	-	-	B-NP	HYPH	O	25	NMOD	O
T7	I-Entity	401	407	kappaB	kappaB	I-NP	NN	B-DNA	25	NMOD	B-DNA
T7	I-Entity	408	412	site	site	I-NP	NN	I-DNA	17	PMOD	I-DNA
O	O	413	415	in	in	B-PP	IN	O	25	NMOD	O
O	O	416	421	human	human	B-NP	JJ	B-cell_line	31	NMOD	B-cell_line
O	O	422	426	8e51	8e51	I-NP	CD	I-cell_line	31	NMOD	I-cell_line
O	O	427	428	T	T	I-NP	NN	I-cell_line	31	NMOD	I-cell_line
O	O	428	429	-	-	I-NP	HYPH	I-cell_line	31	NMOD	I-cell_line
O	O	429	434	cells	cell	I-NP	NNS	I-cell_line	26	PMOD	I-cell_line
O	O	434	435	,	,	O	,	O	31	P	O
O	O	436	440	that	that	B-NP	WDT	O	31	NMOD	O
O	O	441	448	harbour	harbour	B-VP	VBP	O	33	SBAR	O
O	O	449	450	a	a	B-NP	DT	O	37	NMOD	O
O	O	451	460	defective	defective	I-NP	JJ	O	37	NMOD	O
O	O	461	464	HIV	HIV	I-NP	NN	O	39	NMOD	O
O	O	464	465	-	-	B-NP	HYPH	O	39	P	O
O	O	465	466	1	1	I-NP	CD	O	34	OBJ	O
O	O	466	467	.	.	O	.	O	5	P	O

O	O	468	470	At	At	B-NP	IN	O	9	NMOD	O
O	O	471	476	least	least	I-NP	JJS	O	1	AMOD	O
O	O	477	481	four	four	I-NP	CD	O	1	AMOD	O
O	O	482	491	different	different	I-NP	JJ	O	5	AMOD	O
O	O	492	500	specific	specific	I-NP	JJ	O	9	NMOD	O
T9	B-Entity	501	503	NF	NF	I-NP	NN	B-protein	8	NMOD	B-protein
T9	I-Entity	503	504	-	-	I-NP	HYPH	I-protein	8	P	I-protein
T9	I-Entity	504	510	kappaB	kappaB	I-NP	NN	I-protein	9	NMOD	I-protein
T9	I-Entity	511	520	complexes	complex	I-NP	NNS	I-protein	10	SUB	I-protein
O	O	521	524	are	be	B-VP	VBP	O	0	ROOT	O
O	O	525	532	present	present	B-ADJP	JJ	O	10	PRD	O
O	O	533	535	in	in	B-PP	IN	O	11	AMOD	O
O	O	536	539	the	the	B-NP	DT	O	14	NMOD	O
O	O	540	547	nucleus	nucleus	I-NP	NN	O	12	PMOD	O
O	O	548	550	of	of	B-PP	IN	O	14	NMOD	O
O	O	551	556	these	these	B-NP	DT	O	17	NMOD	O
O	O	557	562	cells	cell	I-NP	NNS	O	15	PMOD	O
O	O	562	563	.	.	O	.	O	10	P	O

O	O	564	568	With	With	B-PP	IN	O	8	VMOD	O
O	O	569	572	the	the	B-NP	DT	O	3	NMOD	O
O	O	573	576	use	use	I-NP	NN	O	1	PMOD	O
O	O	577	579	of	of	B-PP	IN	O	3	NMOD	O
O	O	580	588	specific	specific	B-NP	JJ	B-protein	6	NMOD	B-protein
O	O	589	599	antibodies	antibody	I-NP	NNS	I-protein	4	PMOD	I-protein
O	O	600	602	we	we	B-NP	PRP	O	8	SUB	O
O	O	603	607	have	have	B-VP	VBP	O	0	ROOT	O
O	O	608	618	determined	determine	I-VP	VBN	O	8	VC	O
O	O	619	622	the	the	B-NP	DT	O	11	NMOD	O
O	O	623	634	composition	composition	I-NP	NN	O	9	OBJ	O
O	O	635	637	of	of	B-PP	IN	O	11	NMOD	O
O	O	638	642	each	each	B-NP	DT	O	14	NMOD	O
O	O	643	650	complex	complex	I-NP	NN	O	12	PMOD	O
O	O	651	656	using	use	B-VP	VBG	O	8	VMOD	O
O	O	657	672	electrophoretic	electrophoretic	B-NP	JJ	O	19	NMOD	O
O	O	673	681	mobility	mobility	I-NP	NN	O	19	NMOD	O
O	O	682	687	shift	shift	I-NP	NN	O	19	NMOD	O
O	O	688	694	assays	assay	I-NP	NNS	O	15	OBJ	O
O	O	694	695	.	.	O	.	O	8	P	O

O	O	696	699	The	The	B-NP	DT	O	2	NMOD	O
O	O	700	707	results	result	I-NP	NNS	O	3	SUB	O
O	O	708	712	show	show	B-VP	VBP	O	0	ROOT	O
O	O	713	716	the	the	B-NP	DT	O	5	NMOD	O
O	O	717	725	presence	presence	I-NP	NN	O	3	OBJ	O
O	O	726	728	of	of	B-PP	IN	O	5	NMOD	O
O	O	729	736	several	several	B-NP	JJ	O	12	NMOD	O
O	O	737	739	NF	NF	I-NP	NN	O	12	NMOD	O
O	O	739	740	-	-	I-NP	HYPH	O	12	P	O
O	O	740	746	kappaB	kappaB	B-NP	NN	B-protein	12	NMOD	B-protein
O	O	747	753	family	family	I-NP	NN	I-protein	12	NMOD	I-protein
O	O	754	761	members	member	I-NP	NNS	I-protein	6	PMOD	I-protein
O	O	761	762	,	,	O	,	O	3	P	O
O	O	763	767	with	with	B-PP	IN	O	3	VMOD	O
O	O	768	771	the	the	B-NP	DT	O	17	NMOD	O
O	O	772	787	transactivating	transactivate	I-NP	VBG	O	17	NMOD	O
T1	B-Protein	788	792	RelA	RelA	I-NP	NN	B-protein	18	SUB	B-protein
O	O	793	798	being	be	B-VP	VBG	O	14	PMOD	O
O	O	799	806	engaged	engage	I-VP	VBN	O	18	VC	O
O	O	807	809	in	in	B-PP	IN	O	19	VMOD	O
T10	B-Entity	810	818	multiple	multiple	B-NP	JJ	O	22	NMOD	O
T10	I-Entity	819	828	complexes	complex	I-NP	NNS	O	20	PMOD	O
O	O	828	829	.	.	O	.	O	3	P	O

O	O	830	833	The	The	B-NP	DT	O	2	NMOD	O
O	O	834	844	importance	importance	I-NP	NN	O	11	SUB	O
O	O	845	847	of	of	B-PP	IN	O	2	NMOD	O
T11	B-Entity	848	850	NF	NF	B-NP	NN	B-protein	7	NMOD	B-protein
T11	I-Entity	850	851	-	-	B-NP	HYPH	I-protein	7	NMOD	I-protein
T11	I-Entity	851	857	kappaB	kappaB	I-NP	NN	I-protein	7	NMOD	I-protein
T11	I-Entity	858	867	complexes	complex	I-NP	NNS	I-protein	3	PMOD	I-protein
O	O	868	870	in	in	B-PP	IN	O	2	NMOD	O
O	O	871	876	viral	viral	B-NP	JJ	O	10	NMOD	O
O	O	877	886	functions	function	I-NP	NNS	O	8	PMOD	O
O	O	887	890	has	have	B-VP	VBZ	O	0	ROOT	O
O	O	891	895	been	be	I-VP	VBN	O	11	VC	O
O	O	896	907	established	establish	I-VP	VBN	O	12	VC	O
O	O	908	917	comparing	compare	B-VP	VBG	O	11	VMOD	O
O	O	918	921	the	the	B-NP	DT	O	16	NMOD	O
O	O	922	927	level	level	I-NP	NN	O	14	OBJ	O
O	O	928	930	of	of	B-PP	IN	O	16	NMOD	O
T12	B-Entity	931	933	NF	NF	B-NP	NN	B-protein	20	NMOD	B-protein
T12	I-Entity	933	934	-	-	O	HYPH	I-protein	20	NMOD	I-protein
T12	I-Entity	934	940	kappaB	kappaB	B-NP	NN	I-protein	24	NMOD	I-protein
T12	I-Entity	941	944	DNA	DNA	I-NP	NN	O	24	NMOD	O
T12	I-Entity	944	945	-	-	O	HYPH	O	21	P	O
T12	I-Entity	945	952	binding	bind	B-VP	VBG	O	24	NMOD	O
T12	I-Entity	953	962	complexes	complex	B-NP	NNS	O	17	PMOD	O
O	O	963	967	with	with	B-PP	IN	O	14	VMOD	O
O	O	968	976	syncytia	syncytia	B-NP	NN	O	25	PMOD	O
O	O	976	977	-	-	O	HYPH	O	26	P	O
O	O	977	984	forming	form	B-VP	VBG	O	26	NMOD	O
O	O	985	993	activity	activity	B-NP	NN	O	28	OBJ	O
O	O	994	996	of	of	B-PP	IN	O	29	NMOD	O
O	O	997	1001	8e51	8e51	B-NP	NN	B-cell_line	32	NMOD	B-cell_line
O	O	1002	1007	cells	cell	I-NP	NNS	I-cell_line	30	PMOD	I-cell_line
O	O	1007	1008	.	.	O	.	O	11	P	O

O	O	1009	1011	In	In	B-PP	IN	O	15	VMOD	O
O	O	1012	1016	fact	fact	B-NP	NN	O	1	PMOD	O
O	O	1016	1017	,	,	O	,	O	15	P	O
O	O	1018	1022	8e51	8e51	B-NP	NN	B-cell_line	5	NMOD	B-cell_line
O	O	1023	1028	cells	cell	I-NP	NNS	I-cell_line	15	SUB	I-cell_line
O	O	1029	1033	that	that	B-NP	WDT	O	5	NMOD	O
O	O	1034	1037	had	have	B-VP	VBD	O	6	SBAR	O
O	O	1038	1044	almost	almost	I-VP	RB	O	7	VMOD	O
O	O	1045	1049	lost	lose	I-VP	VBN	O	7	VC	O
O	O	1050	1055	their	their	B-NP	PRP$	O	11	NMOD	O
O	O	1056	1064	syncytia	syncytia	I-NP	NN	O	9	OBJ	O
O	O	1064	1065	-	-	O	HYPH	O	11	P	O
O	O	1065	1072	forming	form	B-VP	VBG	O	11	NMOD	O
O	O	1073	1081	capacity	capacity	B-NP	NN	O	13	OBJ	O
O	O	1082	1086	were	be	B-VP	VBD	O	0	ROOT	O
O	O	1087	1092	found	find	I-VP	VBN	O	15	VC	O
O	O	1093	1095	to	to	I-VP	TO	O	18	VMOD	O
O	O	1096	1103	contain	contain	I-VP	VB	O	16	VMOD	O
O	O	1104	1106	at	at	B-NP	IN	O	18	VMOD	O
O	O	1107	1112	least	least	I-NP	JJS	O	19	AMOD	O
O	O	1113	1115	10	10	I-NP	CD	O	19	AMOD	O
O	O	1116	1121	times	time	I-NP	NNS	O	19	AMOD	O
O	O	1122	1126	less	less	I-NP	RBR	O	19	AMOD	O
O	O	1127	1133	active	active	I-NP	JJ	O	28	NMOD	O
T15	B-Entity	1134	1136	NF	NF	I-NP	NN	B-protein	27	NMOD	B-protein
T15	I-Entity	1136	1137	-	-	O	HYPH	I-protein	27	NMOD	I-protein
T15	I-Entity	1137	1143	kappaB	kappaB	B-NP	NN	I-protein	28	NMOD	I-protein
T15	I-Entity	1144	1147	DNA	DNA	I-NP	NN	O	19	PMOD	O
T15	I-Entity	1147	1148	-	-	O	HYPH	O	28	P	O
T15	I-Entity	1148	1155	binding	bind	B-VP	VBG	O	31	NMOD	O
T15	I-Entity	1156	1163	complex	complex	B-NP	NN	O	28	NMOD	O
O	O	1164	1168	than	than	B-PP	IN	O	28	NMOD	O
O	O	1169	1172	the	the	B-NP	DT	O	36	NMOD	O
O	O	1173	1181	actively	actively	I-NP	RB	B-cell_type	36	NMOD	B-cell_type
O	O	1182	1188	fusing	fuse	I-NP	VBG	I-cell_type	36	NMOD	I-cell_type
O	O	1189	1194	cells	cell	I-NP	NNS	I-cell_type	32	PMOD	I-cell_type
O	O	1194	1195	.	.	O	.	O	15	P	O

O	O	1196	1199	The	The	B-NP	DT	O	2	NMOD	O
O	O	1200	1211	correlation	correlation	I-NP	NN	O	3	SUB	O
O	O	1212	1214	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	1215	1223	specific	specific	B-ADJP	JJ	O	3	PRD	O
O	O	1224	1226	as	as	B-SBAR	IN	O	3	VMOD	O
O	O	1227	1230	the	the	B-NP	DT	O	7	NMOD	O
O	O	1231	1236	level	level	I-NP	NN	O	15	SUB	O
O	O	1237	1239	of	of	B-PP	IN	O	7	NMOD	O
O	O	1240	1242	at	at	B-NP	IN	O	12	NMOD	O
O	O	1243	1248	least	least	I-NP	JJS	O	9	AMOD	O
O	O	1249	1254	three	three	I-NP	CD	O	9	AMOD	O
O	O	1255	1260	other	other	I-NP	JJ	O	8	PMOD	O
O	O	1261	1274	transcription	transcription	I-NP	NN	B-protein	14	NMOD	B-protein
O	O	1275	1282	factors	factor	I-NP	NNS	I-protein	12	NMOD	I-protein
O	O	1283	1286	did	do	B-VP	VBD	O	5	SBAR	O
O	O	1287	1290	not	not	I-VP	RB	O	15	VMOD	O
O	O	1291	1297	change	change	I-VP	VB	O	15	VC	O
O	O	1297	1298	.	.	O	.	O	3	P	O
